2016 was a wild ride; what can we expect in 2017? What does it take to go IPO and when are acquirers engaging in M&A? This presentation will explore the current state of the BioPharma venture world and include the following topics:
• What does it take to go IPO and when are acquirers engaging in M&A?
• Explore current equity financings vs. the last three years
• Analysis of which venture firms are most active
• The crossover phenomenon and what does it mean for your company?
- Which crossovers are investing and at which stage
- Step-up in private equity rounds
- IPO pre-money valuation and IPO success
• Exits: the trend to early stage M&A in Biopharma, and explore time to exit, up front and all-in values, and multiples on capital invested by indication.
- Types of IPOs completed since 2013 and changes in 2016
- Average dollars raised and pre money by indication
At the end of this talk you should be informed as to who is investing in BioPharma and comps for M&A and IPO in your indication.
11:30am | Registration and Networking Lunch
12:00pm | Presentation and Q&A
1:00pm | Close
In cooperation with BioPharma Consortium
Jonathan Norris | Managing Director, Silicon Valley Bank
Jonathan Norris is a managing director for SVB's Healthcare practice. Norris oversees business development efforts for banking and lending opportunities as well as spearheading strategic relationships with many healthcare venture capital firms. He also helps SVB Capital through sourcing and advising on limited partnership allocations. In addition, he speaks at major investor and industry conferences and authors widely cited analyses of healthcare venture capital trends. Norris has more than sixteen years of banking experience working with healthcare companies and venture capital firms. Norris earned a bachelor's degree in business administration from the University of California, Riverside and a juris doctorate from Santa Clara University.
$15 | General Public
$10 | Student/Academic
$25 | Onsite
3210 Merryfield Row
San Diego, CA
Save This Event
When & Where
JLABS San Diego
JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.